Bibliography
- DALVIE D: Recent advances in the applications of radioisotopes in drug metabolism, toxicology and pharmacokinetics. Curr. Pharm. Des. (2000) 6(10):1009–1028.
- ROBERTS D, LOCKLEY R: Radiosynthesis a vital role supporting drug development. Drug Discov. World (2004):59–62.
- CALDWELL J, GARDNER I, SWALES N: An introduction to drug disposition: the basic principles of absorption, distribution, metabolism and excretion. Toxicol. Pathol. (1995) 23(2):102–114.
- WORLD HEALTH ORGANISATION: Use of ionising radiation and radionuclides on human beings for medical purposes. Technical report series. Geneva, Switzerland (1977).
- INTERNATIONAL COMMISSION on RADIOLOGICAL PROTECTION: Recommendations of the International Commission on Radiological Protection. ICRP Publication 60. Ann. ICRP (1991) 21.
- INTERNATIONAL COMMISSION on RADIOLOGICAL PROTECTION: Radiological protection in biomedical research. ICRP Publication 62. Ann. ICRP (1991) 33(3).
- YOUNG G, AYRTON J, PATMAN A: Isotopic drug studies in man, Chapter 11. In: Handbook of Bioanalysis and Drug Metabolism. G Evans (Ed.), CRC Press, Boca Raton, USA (2004).
- L’ANNUNZIATA MF, KESSLER MJ: Radiotracer liquid scintillation analysis. In: Handbook of Radioactive Analysis. MF L’Annunziata (Ed.), Academic Press, USA (1998).
- WHITE IN, BROWN K :Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology. Trends Pharmacol. Sci. (2004) 25(8):442–447.
- LAPPIN G, GARNER RC: Current perspectives on 14C isotope measurement in biomedical accelerator mass spectrometry. Anal. Bioanal. Chem. (2004) 378:356–364.
- LAPPIN G, GARNER RC: Ultra-sensitive detection of radiolabelled drugs and their metabolites using accelerator mass spectrometry. In: Handbook of analytical separations. RM Smith, I Wilson (Eds), Amsterdam, The Netherlands (2003).
- YOUNG G, ELLIS W, AYRTON J, HUSSEY E, ADAMKIEWICZ B: Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the technique. Xenobiotica (2001) 31(8/9):619–632.
- TURTELTAUB KW, VOGEL JS: Bioanalytical applications of accelerator mass spectrometry for pharmaceutical research. Curr. Pharm. Des. (2000) 6(10):991–1007.
- WALDMEIER F, GARNER C: Application of AMS for human ADME. Drug Metab. Rev. (2001) 33:121.
- LIBERMAN RG, TANNENBAUM SR, HUGHEY BJ et al.: An interface for direct analysis of (14)c in nonvolatile samples by accelerator mass spectrometry. Anal. Chem. (2004) 76:328–334.
- STRONG JM, DUTCHER JS, LEE WK, ATKINSON AJ: Absolute bioavailability in man of N-acetylprocainamide determined by a novel stable isotope method. Clin. Pharmacol. Ther. (1975) 18(5 pt 1):613–622.
- BROWNE TR: Stable isotopes in clinical pharmacokinetics investigations: advantages and disadvantages. Clin. Pharmacokinet. (1990) 18(6):423–433.
- ATKINSON AJ, RUO TI, PIERGIES AA et al.: Pharmacokinetics of N-acetylprocainamide in patients profiles with a stable isotope method. Clin. Pharmacol. Ther. (1989) 46(2):182–189.
- HAGE K, BUHL K, FISCHER C, KNEBEL NG: Estimation of the absolute bioavailability of fecainide using stable isotope technique. Eur. J. Clin. Pharmacol. (1995) 48(1):51–55.
- MIHALY GW, WARD SA, EDWARDS G, NICHOLL DD, ORME ML, BRECKENRIDGE AM: Pharmacokinetics of primaquine in man. I. Studies of the absolute bioavailability and effects of dose size. Br. J. Clin. Pharmacol. (1985) 19(6):745–750.
- LAPPIN G, GARNER RC: Big physics, small doses - the use of AMS and PET in human microdosing of development drugs. Nat. Rev. Drug Disc. (2003) 2:233–240.
- Position paper on non-clinical safety studies to support clinical trials with a single microdose. EMEA Position paper CPMP/ SWP/2599 (2004).
- STOTT AW, BERSTAN R, EVERSHED RP, BRONK-RAMSEY C, HEDGES RE, HUMM MJ: Direct dating of archaeological pottery by compoundspecific 14C analysis of preserved lipids. Anal. Chem. (2003) 75(19):5037–5045.